To assess acute myocardial infarction-related cardiogenic shock (AMI-CS) treatment capacity and management practices among medical institutions at different levels in Beijing.
Approach:
Survey Design: A questionnaire was developed based on an international survey, comprising 44 questions across five sections to evaluate AMI-CS management.
Hospital Sampling: Data were collected from 61 hospitals in two quality-control networks and 89 additional hospitals using a multistage sampling strategy.
Hospital Classification: Hospitals were classified into Level 1, Level 2, and Level 3 based on their capacity to manage cardiogenic shock and perform necessary interventions.
Statistical Analysis: Frequencies and percentages were used for categorical variables, with confidence intervals and group differences assessed using chi-square or Fisher’s exact tests.
Key Findings:
Marked differences in cardiogenic shock management practices were observed across hospitals in Beijing.
Inequitable resource distribution and inadequate multidisciplinary teams were identified as challenges.
The survey highlighted the need for standardized care pathways and regional care networks.
Interpretation:
The findings indicate significant variability in the management of AMI-CS in Beijing, suggesting a need for improved coordination and resource allocation.
Limitations:
The study may not fully capture the practices in all hospitals due to exclusion criteria.
Responses may be subject to bias based on the knowledge and experience of the respondents.
Conclusion:
Evaluating AMI-CS management in Beijing is crucial for developing national treatment strategies and enhancing clinical outcomes.
The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.
